GLP 10mg Tirzepatide
Add to wishlist Compare

in stock

In stock

GLPs

GLP 10mg Tirzepatide

GLP-3 · Triple-Receptor Agonist

FOR RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION.

$150.00

Add to wishlist Compare
MADE IN THE USA

Manufactured to the highest research-grade standards — synthesized in the USA with 100% American-sourced materials. Every batch is independently third-party tested before release.

Learn about our testing & COAs.
2-Day Fast Shipping
99%+ Purity Tests
Ships Monday–Friday
USA Lab Tested
Note: This product is provided as a lyophilized, research-grade powder and does not come in liquid form.
Available: In stock Categories: ,

Description

GLP Tirzepatide is a high-purity research peptide supplied as a lyophilized powder. Part of the GLP class, Tirzepatide is a next-generation triple-receptor agonist that targets the GLP, GIP, and glucagon receptors — studied for metabolic regulation and body composition. Every batch is 99%+ pure, independently third-party tested, and made & synthesized in the USA. Each vial is sealed for integrity and stability.

Handling: Store in a cool, dry place away from direct sunlight and moisture. Reconstitute with bacteriostatic water (sold separately).

Disclaimer: For Research Use Only. Not for human consumption, medical, veterinary, or household use.

Additional information

Weight0.2 lbs

Next-Generation GLP

The Benefits of GLP

GLP is the newest generation of metabolic research peptide — a triple-receptor agonist studied for a wider range of benefits than first-gen options like semaglutide.

Tap a point to explore ↓

RDAmd GLP vial

GLP is studied for its role in reducing appetite by acting on the brain's satiety centers — helping take the edge off cravings.

By slowing how fast food leaves the stomach, GLP is studied for keeping the body satisfied for longer after meals.

GLP influences insulin and glucagon signaling, studied for its role in healthy glucose regulation and metabolic balance.

First-gen options like semaglutide target a single receptor. Our GLP is the newest generation — a triple agonist that targets three metabolic receptors at once. The most advanced step in the category.

Related products